Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer

dc.contributor.authorRamalho-Carvalho, João
dc.contributor.authorGraça, Inês
dc.contributor.authorGómez, Antonio
dc.contributor.authorOliveira, Jorge
dc.contributor.authorHenrique, Rui
dc.contributor.authorEsteller, Manel
dc.contributor.authorJerónimo, Carmen
dc.date.accessioned2019-02-06T16:38:52Z
dc.date.available2019-02-06T16:38:52Z
dc.date.issued2017-02-06
dc.date.updated2019-02-06T16:38:52Z
dc.description.abstractBackground: numerous DNA-damaging cellular stresses, including oncogene activation and DNA-damage response (DDR), may lead to cellular senescence. Previous observations linked microRNA deregulation with altered senescent patterns, prompting us to investigate whether epigenetic repression of microRNAs expression might disrupt senescence in prostate cancer (PCa) cells. Methods: differential methylation mapping in prostate tissues was carried using Infinium HumanMethylation450 BeadChip. After validation of methylation and expression analyses in a larger series of prostate tissues, the functional role of the cluster miR-130b~301b was explored using in vitro studies testing cell viability, apoptosis, invasion and DNA damage in prostate cancer cell lines. Western blot and RT-qPCR were performed to support those observations. Results: we found that the miR-130b~301b cluster directs epigenetic activation of cell cycle inhibitors required for DDR activation, thus stimulating the senescence-associated secretory phenotype (SASP). Furthermore, overexpression of miR-130b~301b cluster markedly reduced the malignant phenotype of PCa cells. Conclusions: altogether, these data demonstrate that miR-130b~301b cluster overexpression might effectively induce PCa cell growth arrest through epigenetic regulation of proliferation-blocking genes and activation of cellular senescence.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec670729
dc.identifier.issn1756-8722
dc.identifier.pmid28166834
dc.identifier.urihttps://hdl.handle.net/2445/127981
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13045-017-0415-1
dc.relation.ispartofJournal of Hematology & Oncology, 2017, vol. 10, num. 1, p. 43
dc.relation.urihttps://doi.org/10.1186/s13045-017-0415-1
dc.rightscc-by (c) Ramalho-Carvalho, João et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)
dc.subject.classificationCàncer de pròstata
dc.subject.classificationFenotip
dc.subject.classificationMicro RNAs
dc.subject.classificationMetilació
dc.subject.classificationCèl·lules canceroses
dc.subject.classificationEnvelliment
dc.subject.otherProstate cancer
dc.subject.otherPhenotype
dc.subject.otherMicroRNAs
dc.subject.otherMethylation
dc.subject.otherCancer cells
dc.subject.otherAging
dc.titleDownregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
670729.pdf
Mida:
1.58 MB
Format:
Adobe Portable Document Format